Trial Profile
Prospective study evaluating application of monitoring Adalimumab (ADL) serum levels and anti-ADL antibodies in rheumatoid arthritis patients treated with Adalimumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jan 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 04 Jan 2016 New trial record